Femoroacetabular impingement (FAI) Surgery
Conditions
Interventions
Hip Arthroscopic Surgery - performed by an experienced trained surgeon.
Non-operative care - this will comprise a package of best conservative care
treatment options, including interventions that target patients? pain (anti-inflammatory medication, hip joint corticosteroid injection, postural adaptations, exercise, acupuncture, manual therapy tec
Sponsors
University Hospitals Coventry & Warwickshire (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 04/02/2013: 1. = 16 years of age 2. They have symptoms of hip pain - they may also have symptoms of clicking, catching or giving way 3. They show radiographic evidence of pincer- or cam-type FAI on plain radiographs and cross-sectional imaging 4. The treating surgeon believes that they would benefit from arthroscopic FAI surgery 5. Able to give written informed consent 6. Able to participate fully in the interventions Previous inclusion criteria until 04/02/2013: 1. Aged 18-50 2. They have symptoms of hip pain - they may also have symptoms of clicking, catching or giving way 3. They show radiographic evidence of pincer- or cam-type FAI on plain radiographs and cross-sectional imaging 4. The treating surgeon believes that they would benefit from arthroscopic FAI surgery 5. Able to give written informed consent 6. Able to participate fully in the interventions
Exclusion criteria
Exclusion criteria: 1. They have previous significant hip pathology such as Perthes? disease, slipped upper femoral epiphysis or avascular necrosis 2. They have had a previous hip injury such as acetabular fracture, hip dislocation or femoral neck fracture 3. They already have osteoarthritis, defined as Tonnis grade >150, or more than 2mm loss of superior joint space width on AP pelvic radiograph 4. There is evidence that the patient would be unable to participate fully in the interventions, adhere to trial procedures or to complete questionnaires, such as cognitive impairment or intravenous drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Non-Arthritic Hip Score (NAHS) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. IHOT-33 2. SF-36 3. EQ-5D | — |
Countries
United Kingdom
Outcome results
None listed